GlassScriptPhysician profile
Connie Williams
NPI 1750735452
$5,776.14
in general payments reported to CMS, 2019-2025
27 companies · $864 in 2025
The $864 reported for 2025 was more than what 85% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,209 · 2022: $1,223 · 2023: $766 · 2024: $714 · 2025: $864.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,345.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,344.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,486.83 | 2021-2025 | Gallant, Assurity, Aveir |
| Medtronic, INC. | $604.18 | 2021-2025 | Symplicity G3, Onyx Frontier |
| Novartis Pharmaceuticals Corporation | $531.87 | 2021-2024 | |
| Merck Sharp & Dohme LLC | $457.39 | 2022-2025 | Verquvo |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $288.14 | 2021-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $281.49 | 2021-2024 | Xarelto |
| Bayer Healthcare Pharmaceuticals INC. | $271.76 | 2021-2025 | |
| Bard Peripheral Vascular, INC. | $258.23 | 2021-2022 | |
| Inari Medical, INC. | $185.60 | 2021 | |
| Pfizer INC. | $165.88 | 2021-2024 | |
| Amgen INC. | $133.69 | 2021-2025 | Repatha, Repatha |
| Edwards Lifesciences Corporation | $117.78 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $115.06 | 2021-2023 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $113.96 | 2021-2024 | Farxiga |
| Cardiovascular Systems INC. | $109.39 | 2021 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Terumo Medical Corporation | $101.13 | 2021 | |
| Philips North America LLC | $94.32 | 2024-2025 | Lm Undivided, (5091) Amb Mon & Diag Und |
| E.R. Squibb & Sons, L.L.C. | $74.58 | 2021-2022 | |
| Boston Scientific Corporation | $70.93 | 2023-2024 | Watchman, Watchman Access System, Eluvia |
| Scpharmaceuticals INC. | $69.92 | 2024-2025 | |
| Genentech USA, INC. | $56.64 | 2023 | Phesgo, Perjeta, Kadcyla |
| Inspire Medical Systems, INC. | $49.91 | 2023-2025 | Inspire |
| Shockwave Medical, INC | $33.31 | 2022-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Novo Nordisk INC | $33.17 | 2021-2025 | Wegovy |
| Lexicon Pharmaceuticals, INC. | $29.94 | 2023-2024 | Inpefa |
| Kestra Medical Technology Services, INC. | $21.96 | 2025 | Assure Wcd |
| Impulse Dynamics (USA) INC. | $19.08 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Connie Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.